Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

AngioDynamics Inc ANGO

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.


NDAQ:ANGO - Post by User

<< Previous
Bullboard Posts
Post by investorblingon Jan 04, 2007 10:52am
280 Views
Post# 11954841

Recommendations for January 4, 2007

Recommendations for January 4, 2007

The Bomb

Company Recommendation Current Price Target Price  Analyst  Analyst Rating 
Duke Energy Corp. Outperform  $19.14  $20.75  K.T.  3 Stars 
Spectra Energy Corp.  Market Perform  $28.62  $28.00  K.T.  3 Stars 
Compton Petroleum Corp.  Market Perform $10.00  $11.75  M.L.  3.5 Stars 

Concorde

Company  Recommendation  Current Price  Target Price   Analyst  Analyst Rating 
AngioDynamics  Buy  $21.97  $28.00  M.S.  -------- 
GlobalOptions Group  Buy  $1.50  $5.00  D.L.  -------- 
Martek Biosciences  Hold  $23.06  $25.00  S.V.W.  3 Stars 
Occam Networks  Buy  $15.39  $22  J.M.  -------- 
UrAsia Energy Ltd.  Buy  $5.00  $6.00  J.T.  3 Stars 
Verint Systems  Buy  $34.84  $39.00  D.L.  -------- 

See I See You

Company  Recommendation  Current Price  Target Price  Analyst   Analyst Rating 

The Great Atlantic & Pacific Tea Company 

Sector Outperformer  $25.64  $32.00  P.C. & M.P  -------- 
Jean Coutu Group Inc.  Sector Performer  $14.20  $13.50  P.C. & M.P.  -------- 

<< Previous
Bullboard Posts